Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.210
0.00 (0.00%)
At close: Apr 28, 2026, 4:00 PM EDT
1.200
-0.010 (-0.83%)
After-hours: Apr 28, 2026, 4:09 PM EDT
Pliant Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -149.34 | -210.3 | -161.34 | -123.32 | -97.26 | |
| Depreciation & Amortization | 1.7 | 2.13 | 1.84 | 1.82 | 1.54 | |
| Loss (Gain) From Sale of Assets | -0.04 | - | - | - | - | |
| Loss (Gain) From Sale of Investments | 3.96 | 2.51 | -4.99 | -1.81 | 1.26 | |
| Stock-Based Compensation | 26.23 | 37.63 | 44.48 | 22.6 | 10.44 | |
| Other Operating Activities | 5.11 | 3.45 | 2.39 | 1.86 | 1.67 | |
| Change in Accounts Receivable | - | - | 1.98 | 0.02 | 7.28 | |
| Change in Accounts Payable | -5.48 | 1.43 | 2.97 | -1.35 | 0.89 | |
| Change in Other Net Operating Assets | -10.46 | 7.66 | -3.7 | 5.55 | -1.26 | |
| Operating Cash Flow | -128.34 | -155.5 | -116.36 | -94.63 | -75.44 | |
| Capital Expenditures | -0.37 | -3.85 | -0.92 | -1.76 | -1.95 | |
| Sale of Property, Plant & Equipment | 0.16 | - | - | - | - | |
| Investment in Securities | 134.51 | 144.19 | -126.09 | -148.44 | 75.65 | |
| Investing Cash Flow | 134.29 | 140.34 | -127.01 | -150.2 | 73.7 | |
| Long-Term Debt Issued | - | 19.91 | - | 9.85 | - | |
| Long-Term Debt Repaid | -32.27 | - | - | - | - | |
| Net Debt Issued (Repaid) | -32.27 | 19.91 | - | 9.85 | - | |
| Issuance of Common Stock | 0.57 | 3.21 | 275.25 | 217.56 | 2.98 | |
| Other Financing Activities | - | - | -0.85 | -0.56 | -0.46 | |
| Financing Cash Flow | -31.7 | 23.12 | 274.41 | 226.85 | 2.53 | |
| Net Cash Flow | -25.74 | 7.95 | 31.03 | -17.98 | 0.78 | |
| Free Cash Flow | -128.71 | -159.35 | -117.28 | -96.39 | -77.4 | |
| Free Cash Flow Margin | - | - | -7422.91% | -995.26% | -1022.13% | |
| Free Cash Flow Per Share | -2.10 | -2.63 | -2.00 | -2.29 | -2.16 | |
| Cash Interest Paid | 2.54 | 2.62 | 1.15 | 0.62 | - | |
| Levered Free Cash Flow | -84.56 | -98.53 | -66.86 | -51.12 | -42.56 | |
| Unlevered Free Cash Flow | -82.96 | -96.64 | -66.07 | -50.62 | -42.56 | |
| Change in Working Capital | -15.94 | 9.09 | 1.25 | 4.22 | 6.92 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.